This inventor holds 2 USPTO granted patents. Top assignee: Institut Pasteur. Active years: 2007-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2009
Title: François-Xavier Berthet: Innovator in Vaccine Development
Introduction
François-Xavier Berthet is a notable inventor based in Paris, France. He has made significant contributions to the field of vaccine development, particularly through his innovative work on strains with modified erp genes. His research aims to enhance vaccine efficacy by decreasing the virulence and persistence of these strains.
Latest Patents
François-Xavier Berthet holds 2 patents. His latest patents include inventions concerning strains where the erp gene is modified, along with vaccine compositions containing these modified strains. The modification of the erp gene is designed to decrease the virulence and persistence of the strains, thereby improving vaccine effectiveness.
Career Highlights
Throughout his career, François-Xavier Berthet has worked with prestigious institutions, including the Institut Pasteur. His work at these institutions has been pivotal in advancing research in vaccine development and infectious diseases.
Collaborations
François-Xavier Berthet has collaborated with notable professionals in his field, including Brigitte Gicquel. These collaborations have contributed to the success of his research and innovations.
Conclusion
François-Xavier Berthet is a distinguished inventor whose work in vaccine development has the potential to significantly impact public health. His innovative approaches to modifying the erp gene demonstrate his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile